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2Abstract
R-loops, which consist of DNA: RNA hybrids and displaced single-strand DNA, are a major threat 
to genome stability. We have previously reported that a key Fanconi anemia protein, FANCD2, 
accumulates on large fragile genes during mild replication stress in a manner depending on R-loops. 
In this study, we found that FANCD2 suppress R-loop levels. Furthermore, we identified FANCD2 
interactions with RNA processing factors, including hnRNP U and DDX47. Our data suggest that 
FANCD2 that accumulates with R-loops in chromatin recruits these factors, thereby promoting 
efficient processing of long RNA transcripts. This may lead to reduction of transcription-
replication collisions, as detected by PLA between PCNA and RNA Polymerase II, and hence, 
lowered R-loop levels. We propose that this mechanism might contribute to maintenance of 
genome stability during mild replication stress.
Short running title: FANCD2 and RNA processing factors resolve R-loops
Key words: FANCD2, R-loops, hnRNP U, DDX47, replication stress
A list of defined abbreviations: FA, Fanconi anemia; MMC, mitomycin C; ICL, interstrand 
crosslink; DEB, diepoxybutane; PCNA, Proliferating Cell Nuclear Antigen; APH, aphidicolin; 
UFB, ultra-fine bridges; dsDNA, double-strand DNA; hnRNP U, heterogeneous nuclear 
ribonucleoprotein U; PLA, proximal ligation assay
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3Introduction
Fanconi anemia (FA) is a hereditary disorder characterized by genome instability, and 
accompanied by various phenotypes including physical abnormalities at birth, small stature, 
progressive development of hematopoietic stem cell failure, myelodysplasia/leukemia and solid 
tumors [1]. FA is caused by mutations in any one of 22 FA genes identified to date [2,3]. Cells 
from FA patients invariably display remarkably elevated levels of mitomycin C (MMC) or DEB-
induced chromosomal breakage and complex chromosomal rearrangements such as quadriradial 
formations. Therefore, the FA gene products are considered to function in a cellular pathway 
(termed FA pathway) for interstrand crosslink (ICL) repair. FANCD2, together with FANCI 
(forming the I-D2 complex), is monoubiquitinated by the FA core complex, leading to its 
accumulation on damaged chromatin (forming microscopically visible “I-D2 foci”). Once localized, 
the complex coordinates a number of critical activities during ICL repair [4]. For example, 
FANCD2 is essential for “unhooking” of the ICL and the recruitment of SLX4/XPF nuclease 
during replication of an ICL-carrying plasmid in xenopus egg extracts [5]. Consistent with this, 
monoubiquitinated FANCD2 is co-immunoprecipitated with SLX4 in chicken DT40 cells [6]. 
Second, FANCD2 can orchestrate homologous recombination (HR) by promoting end resection by 
CtIP nuclease [7,8] or stabilizing nucleoprotein filaments of RAD51 recombinase [9]. 
Besides these activities, it has been suggested that FANCD2 can function to suppress 
replication stress and promote restart of a stalled replication fork. FANCD2 was shown to interact 
with the MCM helicase complex in response to replication stress [10]. In addition to RAD51 and 
BRCA1/2 proteins, FANCD2 protects stalled replication forks from Mre11-mediated degradation 
[11,12]. Recent work further indicates that histone H3K4 methylation by the SETD1A-BOD1L 
complex enforces nucleosome remodeling activity of FANCD2, resulting in suppression of 
degradation of stalled replication forks via RAD51 filament stabilization [13,14].
Treatment of cells with low-dose aphidicolin (APH), a DNA polymerase inhibitor, triggers 
replication stress, resulting in breaks and gaps in a set of specific chromosomal locations, termed 
common fragile sites (CFS; FRA3B, FRA16D, etc) [15,16]. In this situation, very fine bridges 
between sister chromatids during anaphase (termed ultra-fine bridges, UFB) can be observed by 
immunostaining with anti-BLM, PICH, or FANCM antibodies, but they are not detected by DNA 
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4staining specific for dsDNA, and are thus presumed to consist primarily of ssDNA. FANCD2 forms 
sister foci at the roots of UFBs and accumulates at genomic loci containing CFSs during replication 
stress [17]. Recently, it was reported that FANCD2 is also required for efficient DNA replication 
across CFSs, and it maintains stability of the CFSs [18]. 
We previously found, using a ChIP-sequencing approach, that FANCD2 accumulation is 
mostly restricted to the middle portion of large transcribed genes upon mild replication stress [19]. 
These large genes often correspond to the known CFSs where transcription complexes may collide 
with replication forks in S phase, causing formation of R-loops and CFS expression. R-loops, 
which consist of DNA: RNA hybrids and displaced single-strand DNA, constitute a major threat 
to genome stability [20]. We also identified that FANCD2 accumulation in chromatin as foci at 
CFSs is dependent on the formation of R-loops. It is intriguing to note that these huge genes are 
highly expressed with essential functions in post-mitotic neurons that have ceased DNA replication 
[21]. Thus, the simultaneous occurrence of transcription and replication across these huge genes is 
prohibited in neurons. If transcription-replication collisions occur in cycling cells, the FANCD2 
function needs to be deployed to reduce the conflicts and replication stress. Indeed, prior studies 
revealed that FANCD2 is required to suppress R-loop levels that reflect transcription-replication 
conflicts [18,22,23]. However, how FANCD2 coordinates this function remains unclear.
Our previous attempts to identify FANCD2 interactors revealed that FANCD2 associates 
with a critical end resection factor, CtIP [7,8]. In the same set of mass spectrometric data, we also 
identified several RNA processing factors, including heterogeneous nuclear ribonucleoprotein 
U (hnRNP U)/SAF-A and DDX47(unpublished). It is known that hnRNP U plays multiple 
important roles, in transcription elongation through an interaction with nuclear actin and RNA 
polymerase II [24,25], in RNA stability control [26], alternative splicing through regulation of 
U2snRNP maturation [27], Xist-mediated transcriptional silencing [28], maintenance of 
chromosome stability [29], and antagonizing R-loop formation after DNA damage [30]. DDX47 
encodes a member of the DEAD box protein family characterized by the conserved domain Asp-
Glu-Ala-Asp (DEAD) that may function as a putative ATP-dependent RNA helicase, but its precise 
role remains unknown [31].
In this study, we confirmed the association of these factors with FANCD2 using Co-
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5immunoprecipitation (Co-IP) as well as a Proximal Ligation Assay (PLA). We also found that R-
loop levels are increased in hnRNP U or DDX47 depleted U2OS cells. Given these results, we 
propose that FANCD2 recruits RNA processing enzymes, including hnRNP U and DDX47, to 
resolve R-loops, and coordinates transcription-replication collisions so as to prevent replication 
fork collapse. 
Results
FANCD2 attenuates collisions between replication and transcription machinery during mild 
replication stress
We have previously reported that FANCD2 accumulates at large transcribed genes, and its 
accumulation depends on formation of R-loops that may be induced by transcription-replication 
collisions during mild replication stress [19]. To observe whether transcription-replication 
collisions occur upon replication stress in our condition, we wished to detect colocalization of RNA 
polymerase II (Pol II), proliferating cell nuclear antigen (PCNA), and FANCD2 using a proximal 
ligation assay (PLA). PLA can generate strong signals in situ, when two molecules exist within a 
40 nm proximity in cells [32]. Thus we reasoned that we would be able to capture the collision 
events (or persistence of collisions) as well as FANCD2 accumulation in close proximity to the 
respective transcription and replication machineries using this assay and specific antibodies. 
Indeed, higher numbers of PLA signals between Pol II and PCNA were generated in cells 
treated with APH (Figure 1A), indicating that transcription-replication collision occurs in APH-
treated cells. Furthermore, we observed increased numbers of PLA dots after APH stimulation 
between PCNA and FANCD2 or between FANCD2 and Pol II (Figure 1A), consistent with the 
possibility that FANCD2 accumulates at the regions where transcription-replication conflicts occur. 
In these experiments, FANCD2 was detected by anti-FLAG antibody since we used U2OS-D2-
FLAG cells that carry a 3x FLAG tag in-frame at the FANCD2 C-terminus. This is also consistent 
with our previously published observation that PLA between FANCD2 and a DNA: RNA hybrid-
specific antibody S9.6 are increased upon replication stress [19]. In FANCD2-depleted cells, 
greater numbers of PLA signals between PCNA and Pol II were observed following APH treatment 
compared to control cells (Figure 1B). Taken together, these data suggest that FANCD2 may have 
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6an activity that attenuates transcription-replication collisions during mild replication stress.
Role of FANCD2 in suppression of R-loop levels
Previous studies indicated a role of FANCD2 as well as FANCA in suppression of R-loops in 
unstimulated HeLa cells [22] or in U2OS cells [23] (without replication stress). Given the apparent 
role of FANCD2 in transcription-replication coordination at large genes [19], we decided to 
evaluate R-loop levels in U2OS cells depleted of FANCD2 upon APH treatment using 
immunohistochemistry with the S9.6 antibody. As in previous studies, and consistent with R-loops 
being normal components of the human cell genome, we observed high background levels of S9.6 
immuno-reactive foci in cells without APH treatment, which was decreased by RNaseH1 
expression (Figure 2A). However, a mild increase in the R-loop levels was reproducibly observed 
in APH stimulated cells, and the levels were further enhanced by siFANCD2 treatment (Figure 
2B), implying that FANCD2 may have a protective role in the face of R-loop formation during 
replication stress. The difference was not huge but we interpret that this could be due to high levels 
of R-loops as normal components of the genome and replication stress may occur only at some 
genomic loci such as common fragile sites [19].
FANCD2 interacts with RNA processing factor hnRNP U and DDX47
Mechanistically how FANCD2 affects transcription-replication collisions or suppresses R-loop 
levels is an important question. It has been suggested that FANCM [22] or FANCJ [33] might 
regulate R-loop levels; however, it remains unclear whether FANCD2 exerts any impact on the 
activity of these enzymes. We note that some RNA binding proteins have been reported to prevent 
genome instability and R-loop formation [34]. For example, defects in RNA-processing factors 
such as ASF/SF2, THO/TREX complex, U2 snRNP, DDX19, DDX23 and other RNA biogenesis 
factors induce R-loop-associated genome instability [35-40]. Our mass spectrometry analysis 
indicated that a purified FANCD2 complex isolated from hydroxyurea-treated HeLa S3 cells [7] 
contained such factors, including hnRNP U and DDX47 (Figure 3A and B). Two recent studies 
also listed hnRNP U and DDX47 among FANCD2-associated proteins [10,41]. 
To confirm this observation, we co-immunoprecipitated endogenous hnRNP U or DDX47 
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7with FANCD2 tagged with 3xFLAG from U2OS-D2-FLAG cell lysates. In both cases, we 
successfully detected the interaction (Figure 4A and B), though it was not appreciably increased 
after APH treatment. The co-immunoprecipitation (Co-IP) was not mediated by the presence of 
DNA or RNA since the lysates were treated with Benzonase. Although non-ubiquitinated FANCD2 
seemed to be interacting, PLA signals between FANCD2 and hnRNP U or DDX47 were increased 
following replication stress (Figure 4C and D), suggesting that the mode of interaction could be 
altered in the replication stress-induced FANCD2 foci. 
We excluded the possibility that hnRNP U or DDX47 has an upstream role in FA pathway 
activation, since siRNA-mediated hnRNP U or DDX47 depletion had no effect on FANCD2 
monoubiquitination and foci formation upon mild replication stress (Figure 5A-D). Taken together, 
we propose that FANCD2 recruits RNA processing factor hnRNP U and DDX47 when FANCD2 
accumulates at the sites of transcription-replication conflicts involving R-loops.
hnRNP U and DDX47 suppress R-loop levels and function with FANCD2 to resolve 
transcription-replication collisions
It has been well established that deregulated or impaired RNA processing results in elevated 
formation of R-loops [42-44]. Since hnRNP U is an important regulator of splicing, we 
hypothesized that the hnRNP U bound by FANCD2 at the genomic sites under replication stress 
has a function to suppress R-loop levels. Indeed, we found that treatment with siRNA against 
hnRNP U increased the S9.6 foci in both APH-treated and untreated cells (Figure 6A). Similarly, 
when we depleted DDX47 by siRNA in U2OS cells, increased levels of the S9.6 foci were observed 
compared to the cells treated with control siRNA (Figure 6B). Given the previously reported role 
of these factors in RNA metabolism, the elevated levels of R-loops were not surprising. 
Nonetheless, these observations are consistent with the possibility that FANCD2 may function with 
hnRNP U and DDX47 in regulation of R-loops. 
It has been suggested that the presence of R-loops further exacerbates transcription-
replication conflicts by hampering replication fork progression [42-45]. To test whether FANCD2 
and hnRNP U or DDX47 function in an epistatic manner, we measured the transcription-replication 
collision events as PLA signals between PCNA and Pol II. As observed before, FANCD2-depleted 
Page 7 of 27 The FEBS Journal
8cells displayed higher levels of PLA signals after APH treatment. Interestingly, this increase was 
not further enhanced by the additional depletion of hnRNP U or DDX47, suggesting that FANCD2 
and these factors do act in the same pathway to resolve conflicts between transcription and 
replication upon APH treatment. Taken together, we propose that FANCD2 may recruits RNA 
processing enzymes, including hnRNP U and DDX47, to resolve transcription-replication 
collisions during mild replication stress induced by low dose APH treatment. We suggest that the 
collision might be mitigated by suppression of R-loop formation by the actions of these factors on 
RNA transcripts.
Discussion
FANCD2 functions to suppress R-loop levels upon APH-induced replication stress
It has been shown that cells depleted of FA proteins such as FANCD2, FANCA [19,20], or 
FANCD1 (BRCA2) [46] displayed increased levels of R-loops in non-stimulated cycling cells. In 
this study, we showed that R-loop levels were increased in FANCD2-depleted cells following APH 
treatment. We also provided evidence for an interaction of FANCD2 with hnRNP U, an RNA 
binding protein that functions in transcription elongation [24], pre-mRNA splicing [27], mRNA 
stability [26] and more broadly, interphase chromatin structures [29]. Given the function of hnRNP 
U in normal RNA metabolism, it is not surprising that hnRNP U function contributes to the 
regulation of R-loop levels. BRCA2 interacts with TREX-2, an mRNA export factor [46], and 
BRCA1 localizes at transcription termination regions with Senataxin [47], an RNA helicase, and 
these factors might prevent R-loop-mediated genome instability. We suggest that FANCD2 may 
contribute to pre-mRNA splicing at huge fragile gene loci during replication stress by localizing 
hnRNP U to the sites of R-loop formation. 
We showed that FANCD2 also interacts with DDX47, a member of the DEAD box protein 
family. The DEAD box proteins are putative ATP-dependent RNA helicases characterized by the 
conserved Asp-Glu-Ala-Asp (DEAD) motif. Unwinding of the DNA:RNA hybrids by helicases, 
such as Sen1/Senataxin, DDX19, DDX23, and Pif1, destabilizes R-loops and contributes to 
maintain genome stability [38,39,47,48]. 
Our data suggest that DDX47 may belong to this group of helicases. Transcription-
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9replication collisions induce R-loop accumulation that may further impair progression of 
replication forks. Based on the above data, we propose that FANCD2 participates in mediation of 
transcription-replication conflicts via recruitment of these RNA processing factors, and thereby 
contributes to resolve R-loops, and hence, replication stress. It is interesting to note that a recent 
study shows an interaction of FANCD2 and FANCI with splicing factor SF3B1, and proposes their 
role in organizing chromatin domains to ensure coordination of replication and co-transcriptional 
processes [49]. 
Does FANCD2 also recruit other factors to resolve R-loop formation?
Other than RNA processing enzymes, the FA pathway might also provide other means for R-loop 
control. For example, it has been reported that FANCM translocase or FANCJ helicase has an 
activity to resolve DNA: RNA hybrids, and these enzymes may contribute to suppression of R-
loop levels. However, it remains unclear how FANCD2 may regulate these FA proteins. On the 
other hand, BLM helicase, which can also function to resolve DNA:RNA hybrids [50], is known 
to interact with FANCD2 [51] as well as FANCM. 
FANCD2 has been suggested to orchestrate various activities during ICL repair, including 
protection and restart of the stalled replication forks. FANCD2 promotes HR, perhaps by 
stabilizing RAD51 filaments or promoting end resection by recruitment of nucleases like CtIP or 
DNA2. If the HR activity is compromised, the transcription-replication conflicts with stalled forks 
may persist, leading to genomic sequelae. SMARCAL1 and other enzymes promote remodeling 
and reversal of stalled forks, and then the reversed forks are protected from degradation (mediated 
by Mre11 or DNA2) by the actions of FA proteins such as FANCD2, BRCA1, BRCA2, and Rad51 
[11-14,52]. It seems plausible that these proteins can indirectly suppress R-loop 
formation/stabilization upon APH-induced replication stress. It would be interesting to test whether 
the nucleases implicated in the FA pathway, such as FAN1, CtIP, or SLX4 have any role in R-loop 
regulation in addition to their roles in fork restart or HR activities (end resection or Holliday 
junction resolution).
In conclusion, our current work has revealed novel FANCD2 interactions with RNA 
processing factors and their potential involvement in coordination of transcription-replication 
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conflicts and reduction of R-loop levels (Figure 7). These results may expand the previously 
suggested roles of FANCD2 as a master regulator/handler of endogenous replication stress.
Materials and Methods
Cell culture
U2OS cells were cultured in high glucose DMEM (Nacalai Tesque) supplemented with 10% fetal 
calf serum (Gibco). Generation of a derivative of U2OS, which incorporated a 3×FLAG tag into 
the FANCD2 termination codon has been described previously [19]. For replication stress, cells 
were treated with 0.4 M APH for 24 h.
Antibodies and reagents 
The following antibodies were obtained from commercial sources: mouse monoclonal anti-
DNA:RNA (S9.6, Kerafast); rabbit polyclonal anti-nucleolin (ab50279, abcam); mouse 
monoclonal anti-DDDDK-tag (MBL); mouse monoclonal anti-FLAG (M2, Sigma-Aldrich); anti-
FLAG M2 magnetic beads (Sigma); normal mouse IgG (Santa Cruz); rabbit polyclonal anti-
FANCD2 (Novus); mouse monoclonal anti-PCNA (PC10, Santa Cruz); rabbit polyclonal anti-
phospho RNA polymerase II (Ser2, Bethyl); mouse monoclonal anti-hnRNP U (Abcam); rabbit 
polyclonal anti-DDX47 (Abcam); mouse monoclonal anti-tubulin (T5168, Sigma). Aphidicolin 
(Wako) and DMSO (Nacarai Tesque) were used at the indicated concentrations. Human GFP-
RNaseH1 expression vector was previously described [19].
siRNA transfections 
All siRNA duplexes used were purchased from Invitrogen or Sigma. Transfection and co-
transfection were carried out using Lipofectamine RNAiMAX (Invitrogen) according to the 
manufacturer’s instructions. Cells were harvested 72 h after transfection. The individual siRNA 
duplexes used were: 
siFANCD2 (5′-CAGAGUUUGCUUCACUCUCUATT-3′) (Invitrogen) [8]; sihnRNP U (5'-
GGCCGUGGUAGUUACUCAATT-3′) (Invitrogen) [53]; siDDX47 (5'-
CUCCAUGCUCCCUUAACUCCATT-3′) (Invitrogen) [54]; siLuciferase Control (siLuc) (5′-
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UCGAAGUAUUCCGCGUA CGTT-3′) (Invitrogen) [55]. Plasmid transfection was done using 
lipofectamine 3000 (Invitrogen) according to the manufacturer’s instructions.
Mass spectrometric analysis of purified FANCD2 complexes 
Purification of the FANCD2 complex and analysis by liquid chromatography-tandem mass 
spectrometry has been described [7].
Immunohistochemistry and in situ Proximal Ligation Assay (PLA)
Cells cultured on 15-mm coverslips were washed with PBS and fixed with PBS containing 3% 
paraformaldehyde, 2% sucrose, 0.5% Triton-X-100, placed on ice for 30 min, and further 
permeabilized with 0.5% Triton X-100/PBS for 5 min. After blocking with 2% BSA/PBS, cells 
were stained with the indicated primary antibody for 1 hr at RT. For quantification of the S9.6 foci, 
cells were pre-extracted with 0.5% Triton X-100/PBS for 5 min, fixed with 4% paraformaldehyde 
for 10 min, and further extracted with 100% cold methanol at -20℃ for 5 min. Slides were blocked 
with 2% BSA/PBS, then stained with S9.6 antibodies for 1 hr at RT. Alexa Fluor 488-conjugated 
anti-mouse IgG or Alexa Fluor 594-conjugated anti-rabbit IgG (Molecular Probes) were used as 
secondary antibodies. PLA was performed with reagents from DuoLink Biosciences, which were 
used according to the manufacturer’s instructions. Images were captured using a BZ-9000 
fluorescence microscope (Keyence). Quantification of the PLA signal dots and FANCD2 foci was 
carried out using Hybrid cell count software (Keyence). The number of S9.6 foci were enumerated 
using an IN Cell Analyzer 2000 (GE Healthcare). Briefly, the nuclear areas were defined by DAPI 
staining and then anti-nucleolin positive areas (corresponding to nucleoli) were subtracted. The 
nuclear S9.6 foci number was determined in the remaining subnuclear areas.
Immunoprecipitation and immunoblotting
Cells were washed once with PBS and lysed in NETN buffer (150 mM NaCl, 0.5 mM EDTA, 20 
mM Tris-HCl pH8.0, 0.5% NP-40) supplemented with protease inhibitor cocktail (Roche), 25 
unit/ml Benzonase (Millipore), 2 mM MgCl2, and 1 mM Na3VO4, on ice for 30 min. Then lysates 
were briefly sonicated and centrifuged at 14,000 rpm for 10 min. FLAG-tagged proteins, were 
captured using anti-FLAG M2 magnetic beads (Sigma), washed five times with NETN buffer, and 
analyzed by immunoblotting. Samples were separated by SDS-PAGE, transferred to a PVDF 
membrane, and detected. The band intensities of the ubiquitinated (L-form) versus non-
Page 11 of 27 The FEBS Journal
12
ubiquitinated (S-form) FANCD2 were quantified with LAS-4000 ImageQuant TL software (GE 
Healthcare).
Statistical analysis 
Prism (GraphPad Software) was used to perform unpaired two-tailed Student’s t-tests.
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Figure legends
Figure 1. Transcription-replication collision and R-loop accumulation are increased by 
FANCD2-depletion in U2OS cells during mild replication stress
(A) In situ Proximity Ligation Assay (PLA) between PCNA and RNA polymerase II (DMSO, 
n=66; APH, n=66), PCNA and FANCD2 (DMSO, n=59; APH, n=63), or FANCD2 and RNA 
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polymerase II (DMSO, n=108; APH, n=101), in U2OS cells treated with 0.4 M APH for 24 hr. 
In the case of FANCD2/Pol II PLA, U2OS-D2-FLAG cells were used to detect FANCD2 with 
anti-FLAG antibody. PLA signals per nucleus were plotted. P values were calculated by unpaired, 
two-tailed Student’s t test.
(B) PLA signals between PCNA and RNA polymerase II were further increased in FANCD2-
depleted U2OS cells treated with APH (siLuc DMSO, n=55; siLuc APH, n=56; siFANCD2 DMSO, 
n=53; siFANCD2, n=53). Means ± SEM are shown. P-values were calculated by unpaired, two-
tailed Student’s t test. 
Figure 2. Numbers of S9.6 foci are increased by FANCD2 knock-down
(A) S9.6 foci in U2OS cells upon APH treatment. Cells were transfected with an empty vector or 
the RNaseH1 expression plasmid then stained with anti-S9.6 and anti-nucleolin after 24 hr 
(Empty DMSO, n=567; Empty APH, n=514; RNaseH1 DMSO, n=582; RNaseH1 APH, 
n=561). Nucleolin was stained as a marker for nucleolus which was excluded from counting 
of the S9.6 foci. Means ± SEM are shown. P-values were calculated by unpaired, two-tailed 
Student’s t test.
(B) S9.6 foci in U2OS cells depleted of FANCD2 by siRNA upon APH treatment (siLuc DMSO, 
n=1535; siLuc APH, n=1494; siFANCD2 DMSO, n=1530; siFANCD2 APH, n=1500). 
Nucleolin was stained as a marker for nucleolus which was excluded from counting of the S9.6 
foci. Means ± SEM are shown. P-values were calculated by unpaired, two-tailed Student’s t 
test. siFANCD2 or siLuc transfected cells were immunoblotted with anti-FANCD2 or anti-
tubulin (below).
Figure 3. FANCD2 mass spectrometry analysis 
A partial list of FANCD2-associated proteins identified in the mass spectrometry analysis 
previously carried out by Unno et al. [7]. Cells were treated with or without 2 mM HU 
(hyrdroxyurea) for 24 hr and subjected to purification of FANCD2 complex.
Figure 4. FANCD2 interaction with RNA processing factor hnRNP U and DDX47
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(A-B) Co-IP of FANCD2-FLAG and endogenous hnRNP U and DDX47 from U2OS-D2-FLAG 
cells.
(C-D) In situ PLA between FANCD2 and hnRNP U in U2OS cells (DMSO, n=51; APH, n=50) or 
between FANCD2-FLAG and DDX47 in U2OS-D2-FLAG cells treated with APH (DMSO, n=50; 
APH, n=51). Means ± SEM are shown. P-values were calculated by unpaired, two-tailed Student’s 
t test. 
Figure 5. hnRNP U and DDX47 depletion do not affect FA pathway activation 
(A-D) hnRNP U or DDX47 depletion by siRNA had no effect on FANCD2 monoubiquitination 
and foci formation in U2OS cells treated with 0.4 M APH for 24 hr (siLuc DMSO, n=67; siLuc 
APH, n=68; siHNRNP U DMSO, n=63; siHNRNP U APH, n=74 in (A)) (siLuc DMSO, n=53; 
siLuc APH, n=54; siDDX47 DMSO, n=56; siDDX47 APH, n=49 in (C)). Mean number of foci 
per nucleus ± SEM are shown. P-values were calculated by unpaired, two-tailed Student’s t test.
Figure 6. Numbers of S9.6 foci were increased by hnRNP U and DDX47 siRNA knock down
(A-B) hnRNP U or DDX47-depleted U2OS cells displayed increased numbers of S9.6 foci (siLuc 
DMSO, n=1615; siLuc APH, n=1663; siHNRNP U DMSO, n=2320; siHNRNP U APH, n=1745 
in (A)) (siLuc DMSO, n=1444; siLuc APH, n=1308; siDDX47 DMSO, n=1393; siDDX47 APH, 
n=1384 in (B)). The counting of S9.6 foci was carried out as in Figure 2. Means ±SEM are shown. 
P-values were calculated by unpaired, two-tailed Student’s t test.
(C) PLA signals between PCNA and RNA polymerase II were not increased significantly in 
FANCD2 and HNRNP U or DDX47 doubly-depleted U2OS cells compared to FANCD2-depleted 
cells (siLuc DMSO, n=104; siLuc APH, n=107; siHNRNP U APH, n=108; siHNRNP 
U+siFANCD2 APH, n=109; siDDX47 APH, n=111; siDDX47+siFANCD2 APH, n=107; 
siFANCD2 APH, n=109), suggesting that all three proteins function in the same pathway for 
reducing transcription-replication conflicts. Means ± SEM are shown. P-values were calculated by 
two-tailed Student’s t test.
Figure7. A scheme depicting FANCD2 function in R-loop resolution
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(i) FANCD2 accumulates at large transcribed genes, including CFSs. Its accumulation depends on 
R-loops induced by transcription-replication collisions during mild replication stress.
(ii) FANCD2 recruits RNA processing enzymes including hnRNP U and DDX47 to resolve R-
loops.
(iii) FANCD2 may also contribute to stalled fork restart by resolving R-loops. 
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Figure 3
FANCD2-associated proteins
Genes Peptide # HU(-) Peptide # HU(+)
DDX47 3 5
hnRNP U - 2
Matrin3 - 1
SF3B3 - 1
hnRNP R - 1
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